Interleukin-18 gene promoter polymorphisms in women with gestational trophoblastic diseases

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 53, Issue 11, 2008, Pages 853-859

  Kashef, Mohammad Amin ^a   Dehaghani, Alamtaj Samsami ^a   Naeimi, Sirous ^a   Fattahi, Mohammad Javad ^a   Ghaderi, Abbas ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Genetic polymorphisms; Gestational trophoblastic disease; Interleukin 18

Indexed keywords

INTERLEUKIN 18;

ADULT; ALLELE; ARTICLE; CHORIOCARCINOMA; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; TH2 CELL; TROPHOBLASTIC TUMOR;

ADULT; CASE-CONTROL STUDIES; CHORIOCARCINOMA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYDATIDIFORM MOLE; INTERLEUKIN-18; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PROMOTER REGIONS, GENETIC; UTERINE NEOPLASMS;

EID: 57849145667     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Genest DR, Berkowitz RS, Fisher RA, et al: Gestational trophoblastic disease. In World Health Organization Classification of Tumors, Pathology and Genetics: Tumors of the Breast and Female Genital Organs. Edited by FA Tavassoli, P Devilee. Lyon, IARC Press, 2003
2. Ngan HY: Gestational trophoblastic disease. Curr Obstet Gynaecol 2003;13:95-101
3. Ng TV, Wong LC: Diagnosis and management of gestational trophoblastic neoplasia. Best Pract Res Clin Obstet Gynaecol 2003;17:893-903
4. Bowen JM, Chamley L, Mitchell MD, et al: Cytokines of the placenta and extra-placental membranes: Biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta 2002;23:239-256
5. Bazer FW, Spencer TE, Ott TL: Placental interferons. Am J Reprod Immunol 1996;35:297-308
6. Deniz G, Christmas SE, Johnson PM: Soluble mediators and cytokines produced by human CD3- leucocyte clones from decidualized endometrium. Immunology 1996;87:92-98
7. Nakanishi K, Yoshimoto T, Tsutsui H, et al: Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001;19:423-474
8. Xu D, Trajkovic V, Hunter D, et al: IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background. Eur J Immunol 2000;30:3147-3156
9. Nakanishi K, Yoshimoto T, Tsutsui H, et al: Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001;12:53-72
10. Menon R, Lombardi SJ, Fortunato SJ: IL-18, a product of choriodecidual cells, increases during premature rupture of membranes but fails to turn on the Fas-FasL-mediated apoptosis pathway. J Assist Reprod Genet 2001;18:276-284
11. Ledee-Bataille N: Secreted cytokines in the uterine lumina are predictive of subsequent implantation: Presence of IL18 in the uterine flushing. J Gynecol Obstet Biol Reprod (Paris) 2004;33:S29-S32
12. Ida A, Tsuji Y, Muranaka J, et al: IL-18 in pregnancy: The el-evation of IL-18 in maternal peripheral blood during labour and complicated pregnancies. J Reprod Immunol 2000;47: 65-74
13. Giedraitis V, He B, Huang WX, et al: Cloning and mutation analysis of the human IL-18 promoter: A possible role of polymorphisms in expression regulation. J Neuroimmunol 2001;112:146-152
14. Mojtahedi Z, Naeimi S, Farjadian S, et al: Association of IL-18 promoter polymorphisms with predisposition to Type 1 diabetes. Diabet Med 2006;23:235-239
15. Kretowski A, Mironczuk K, Karpinska A, et al: Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes 2002;51:3347-3349
16. Heinzmann A, Gerhold K, Ganter K, et al: Association study of polymorphisms within interleukin-18 in juvenile idiopathic arthritis and bronchial asthma. Allergy 2004;59: 845-849
17. Sivalingam SP, Yoon KH, Koh DR, et al: Single-nucleotide polymorphisms of the interleukin-18 gene promoter region in rheumatoid arthritis patients: Protective effect of AA genotype. Tissue Antigens 2003;62:498-504
18. Pratesi C, Bortolin MT, Bidoli E, et al: Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother 2006;55:23-30
19. Zhang PA, Wu JM, Li Y, et al: Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. World J Gastroenterol 2005;11:1594-1598
20. Naeimi S, Ghiam AF, Mojtahedi Z, et al: Interleukin-18 gene promoter polymorphisms and recurrent spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 2006;128:5-9
21. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215
22. Kelemen K, Paldi A, Tinneberg H, et al: Early recognition of pregnancy by the maternal immune system. Am J Reprod Immunol 1998;39:351-355
23. Jacobsson B, Holst RM, Mattsby-Baltzer I, et al: Interleukin-18 in cervical mucus and amniotic fluid: Relationship to microbial invasion of the amniotic fluid, intra-amniotic inflammation and preterm delivery. Br J Obstet Gynaecol 2003;110: 598-603
24. Menon R, Lombardi SJ, Fortunato SJ: IL-18, a product of choriodecidual cells, increases during premature rupture of membranes but fails to turn on the Fas-FasL-mediated apoptosis pathway. J Assist Reprod Genet 2001;18:276-284
25. Pacora P, Romero R, Maymon E, et al: Participation of the novel cytokine interleukin 18 in the host response to intraamniotic infection. Am J Obstet Gynecol 2000;183:1138-1143
26. Le Page C, Ouellet V, Madore J, et al: From gene profiling to diagnostic markers: IL-18 and FGF-2 complement CA125 as serum-based markers in epithelial ovarian cancer. Int J Cancer 2006;118:1750-1758
27. Akahiro J, Konno R, Ito K, et al: Impact of serum interleukin-18 level as a prognostic indicator in patients with epithelial ovarian carcinoma. Int J Clin Oncol 2004;9:42-46
28. Gunel N, Coskun U, Sancak B, et al: Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients. Cancer 2002;95:663-667
29. Lissoni P, Brivio F, Rovelli F, et al: Serum concentrations of interleukin-18 in early and advanced cancer patients: Enhanced secretion in metastatic disease. J Biol Regul Homeost Agents 2000;14:275-277
30. Liang XH, Cheung W, Heng CK, et al: Reduced transcriptional activity in individuals with IL-18 gene variants detected from functional but not association study. Biochem Biophys Res Commun 2005;338:736-741